Point72 Hong Kong LTD Iveric Bio, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $12,549 - $24,817	-1,335 Reduced 6.55%	19,055 $342,000
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $185,956 - $385,371	20,390 New	20,390 $196,000
Q1 2022 May 16, 2022	SELL	$12.15 - $16.83 $29,002 - $40,173	-2,387 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $33,012 - $44,827	2,387 New	2,387 $40,000
Q3 2021 Nov 15, 2021	SELL	$7.07 - $17.5 $12,040 - $29,802	-1,703 Closed	0 $0

Q2 2021 Aug 16, 2021	BUY	$5.69 - $7.17 $9,690 - $12,210	1,703 New	1,703 $11,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.